Jelf pays maiden dividend
Independent financial services consultancy Jelf lifted full year revenue and offered a maiden dividend payment despite volatile and uncertain markets.
Independent financial services consultancy Jelf lifted full year revenue and offered a maiden dividend payment despite volatile and uncertain markets.
Pre-tax profit rose to £3.9m for the year ended September 30th 2012 from £3.2m the year before. Revenue for the period increased to £73m from £72.1m the year before.
Earnings per share increased 23% to 3.2p while net cash increased to £2.8m from net debt position of £3m the year before.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sales at its insurance business rose 3% to £46.1m as margins improve.
"Bearing in mind the continuing soft insurance premium rating environment and intense competition at renewal, the 3% increase in Jelf Insurance Brokers revenue represents a good outcome and compares favourably with market growth in our core segments and with the performance of our key competitors," the group said in a statement.
Organic sales in the healthcare division of the employee benefits business rose 4.4% to £11.9m.
Chief Executive Alex Alway commented: "Strong trading during 2011/12 has enabled us to increase our income whilst the EBTIDAE profit margin has improved to 15% from 14% in 2011."
Trading since the start of October has been in line with company expectations and it is confident of further progress in the financial year ahead.
A maiden dividend payment of 1.3p per share has been announced to shareholders on the register by December 28th 2012.
CJ
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published